EBV VCA IgG Rapid Test

Rapid detection of Epstein-Barr virus (EBV) antibodies can help support the investigation of EBV infection and an individual's EBV antibody profile. Biopanda offers EBV VCA IgG Rapid Tests for the qualitative detection of IgG antibodies to the Epstein-Barr virus Viral Capsid Antigen (VCA), providing convenient rapid testing options for healthcare professionals and clinical laboratories. The range includes a dedicated EBV VCA IgG Rapid Test and a combination test for the simultaneous detection of EBV VCA IgG and Epstein-Barr Nuclear Antigen (EBNA) IgG antibodies, enabling different EBV antibody markers to be assessed according to testing requirements.

Why Test for EBV VCA IgG Antibodies?

Epstein-Barr virus (EBV) is a common human herpesvirus and the primary cause of infectious mononucleosis. EBV infection can cause symptoms including fever, sore throat, swollen lymph nodes and fatigue, although the clinical presentation can vary and infection may also occur without noticeable symptoms.

Following EBV infection, the immune system produces antibodies against different components of the virus. Viral Capsid Antigen (VCA) IgG antibodies are one of the serological markers that can be assessed when investigating an individual's EBV antibody profile.

EBV VCA IgG testing may be used alongside other EBV antibody markers, including Epstein-Barr Nuclear Antigen (EBNA) antibodies, to support the interpretation of EBV serological results. The pattern of antibodies detected can provide useful information when considered alongside other appropriate laboratory tests, clinical findings and patient history.

Biopanda offers rapid testing options for EBV VCA IgG antibodies, including a dedicated VCA IgG test and a combined EBV VCA IgG and EBNA IgG Rapid Test, providing healthcare professionals and clinical laboratories with convenient options for qualitative EBV antibody testing.